NJ can regain leadership in pharma by offering modern lab spaces for biotech and other lab-based growth companies.
William Kimmerle
Advertisement
Articles by William Kimmerle
Advertisement
Latest Updated Articles
Building Pharma and Lab Spaces in New Jersey 2021–Adapting to Changing NeedsPublished: March 24th 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Bringing a Breakthrough Rare Disease Product to Patients: Q&A with Helen Sabzevari
2
Roche Announces Positive Topline Results from Phase II Study for Dual GLP-1/GIP Receptor Agonist
3
Boehringer Ingelheim Enters $1.26 Billion Collaboration and License Agreement with Simcere Pharmaceuticals to Develop Pre-Clinical Bispecific Antibody
4
Seamless Therapeutics Enters $1.12 Billion Global Research Collaboration with Eli Lilly to Develop Therapeutics for Hearing Loss
5